Results 91 to 100 of about 1,694,268 (297)

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba, Shweta Bansal, Tea Reljic, Allyne Montecillo‐Aguelo, Hamidah Alias, Farrah Amaranto, Maria Stella Aquino‐Calingasan, Bambang Ardianto, Eggi Arguni, Sally Blair, Thi Tam Dang, Maria Beatriz Gepte, Samanmalee Gunasekara, Andini Handayani, Miriam Kimpo, Catherine G. Lam, Nawachai Lertvivatpong, Sergio Licona, Ana Loseo, Ratha Mlis, Vivian Moreno Berrio, Nguyen Hoai Anh, Anna Lisa Ong‐Lim, Ha Thu Pham, Krishna Sagar Sharma, Bun Sereyleak, Sally Jane G. Velasco‐Aro, Su Yadana, Ambuj Kumar, Sheena Mukkada   +29 more
wiley   +1 more source

What influences clinicians’ decisions about ADHD medication? Initial data from the "influences on prescribing for ADHD questionnaire" (IPAQ) [PDF]

, 2013
Despite evidence for its efficacy and effectiveness, the use of medication for the treatment of ADHD remains controversial. Little is known about the factors that influence clinicians’ decisions to use medication for ADHD.
Thompson, Margaret, Yardley, Lucy, Hodgkins, Paul, Barke, Edmund, Vrijens, May, Danckaerts, Marina, Sonuga-Barke, E, Kovshoff, Hanna   +7 more
core   +1 more source

Trends in migraine-specific medication consumption: a multinational analysis of 73 countries based on IQVIA-MIDAS database, 2015 to 2024

The Journal of Headache and Pain
Background Migraine is a highly prevalent neurological disorder and one of the leading causes of disability worldwide. Despite this immense public health impact, real-world utilization of migraine-specific pharmacotherapies across different income levels
Cuiling Wei, Qiwen Fang, Yifang Huang, Wenxin Tian, Song Song, Xinya Mu, Rachel Yui Ki Chu, Yuqi Hu, Zijie Xu, Xue Li, Ian Chi Kei Wong, Esther Wai Yin Chan, Francisco Tsz Tsun Lai   +12 more
doaj   +1 more source

Medication non-adherence as a driver of pharmaceutical waste: integrating top-down policies with bottom-up practice

Frontiers in Public Health
Medication non-adherence is a widespread challenge affecting up to half of patients with chronic conditions, with profound implications for health outcomes, healthcare costs, and, increasingly recognized, environmental sustainability.
Przemyslaw Kardas, Tamas Agh
doaj   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga, Anne B. Verbeek, Caroline A. Lindemans, Emilie P. Buddingh   +3 more
wiley   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Medication-related harm in New Zealand general practice: a retrospective records review

, 2022
Background: The extent of medication-related harm in general practice is unknown.Aim: To identify and describe all medication-related harm in electronic general practice records.
Alesha J Smith (11908556), Steven Lillis (11850938), Kyle S Eggleton (11908565), Sharon Leitch (2434402), Andrew W McMenamin (11908569), Susan M Dovey (11908547), David M Reith (11908561), Katharine A Wallis (11908562), Wayne K Cunningham (11908550), Martyn I Williamson (11908571), Jiaxu Zeng (6475472)   +10 more
core   +2 more sources

Enhancing Patient Safety and Charge Capture Through Smart Infusion Pump Interoperability: A Health Economic Analysis for US Health Systems

ClinicoEconomics and Outcomes Research
Eric P Borrelli,1 Ashley Taneja,2 Shafiq Abdallah,2 Mia Weiss,2 Nicole S Wilson,3 Idal Beer,3 Julia D Lucaci2 1Health Economics and Outcomes Research, MMS, Becton, Dickinson and Company, San Diego, CA, USA; 2HEOR Strategic Planning, Becton, Dickinson and
Borrelli EP, Taneja A, Abdallah S, Weiss M, Wilson NS, Beer I, Lucaci JD   +6 more
doaj  

Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review

Current Therapeutic Research
Background: Belimumab is the first antibody drug approved for systemic lupus erythematosus (SLE), and is a fully human monoclonal antibody that inhibits soluble B lymphocyte stimulator protein.
Chisato Yoshijima, BSPharm, Yosuke Suzuki, PhD, Ayako Oda, BSPharm, Ryota Tanaka, PhD, Hiroyuki Ono, BSPharm, Hiroki Itoh, PhD, Keiko Ohno, PhD   +6 more
doaj   +1 more source